{
    "root": "36380551-b943-fff8-e063-6394a90a787f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Loxapine",
    "value": "20250528",
    "ingredients": [
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16134"
        },
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "BENZYL ALCOHOL",
            "code": "LKG8494WBH",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17987"
        },
        {
            "name": "BUTYLPARABEN",
            "code": "3QPI1U3FV8",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_88542"
        },
        {
            "name": "EDETATE CALCIUM DISODIUM",
            "code": "25IH6R4SGF",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14598"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31835"
        },
        {
            "name": "POLACRILIN POTASSIUM",
            "code": "0BZ5A00FQU"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32035"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32063"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "SODIUM PROPIONATE",
            "code": "DK6Y9P42IN",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_132106"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "LOXAPINE SUCCINATE",
            "code": "X59SG0MRYU",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6549"
        }
    ],
    "indications": {
        "text": "loxapine capsules indicated treatment schizophrenia . efficacy loxapine schizophrenia established enrolled newly hospitalized chronically hospitalized acutely ill schizophrenic patients subjects .",
        "doid_entities": [
            {
                "text": "schizophrenia (DOID:5419)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5419"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "loxapine capsules administered , usually divided doses , two four times day . daily ( terms base equivalents ) adjusted individual patient \u2019 needs assessed severity symptoms previous history response antipsychotic drugs .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "loxapine capsules , usp available following strengths : loxapine succinate , usp 6.8 mg equivalent 5 mg loxapine , black ink , hard shell , opaque , white body cap , printed \u201c watson 369 \u201d one half \u201c 5 mg \u201d , supplied ndc : 70518-0346-00 packaging : 30 1 blister pack store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . dispense tight , child-resistant container . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "loxapine contraindicated comatose severe drug-induced depressed states ( alcohol , barbiturates , narcotics , etc . ) . loxapine contraindicated individuals known hypersensitivity dibenzoxazepines .",
    "indications_original": "Loxapine capsules are indicated for the treatment of schizophrenia. The efficacy of loxapine in schizophrenia was established in clinical studies which enrolled newly hospitalized and chronically hospitalized acutely ill schizophrenic patients as subjects.",
    "contraindications_original": "Loxapine capsules are administered, usually in divided doses, two to four times a day. Daily dosage (in terms of base equivalents) should be adjusted to the individual patient\u2019s needs as assessed by the severity of symptoms and previous history of response to antipsychotic drugs.",
    "warningsAndPrecautions_original": "Loxapine capsules, USP are available in the following strengths:\n                  Loxapine\u00a0succinate, USP 6.8 mg equivalent to 5 mg loxapine, black ink, hard shell, opaque, with a white body and cap, printed with \u201cWatson 369\u201d\u00a0on one half and \u201c5 mg\u201d\u00a0on the other, are supplied in\n                  \n                  NDC: 70518-0346-00\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  \n                  \n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [See USP Controlled Room Temperature]. Dispense in a tight, child-resistant container.\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Loxapine is contraindicated in comatose or severe drug-induced depressed states (alcohol, barbiturates, narcotics, etc.).\n                  Loxapine is contraindicated in individuals with known hypersensitivity to dibenzoxazepines.",
    "drug": [
        {
            "name": "Loxapine",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50841"
        }
    ]
}